TrialNature medicine2024
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.
Hongnan Mo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it